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ABSTRACT
Cre/LoxP-based DNA recombination has been used
to introduce desired DNA rearrangements in various
organisms, having for example, greatly assisted
genetic analyses in mice. For most applications,
single gene promoters are used to drive Cre pro-
duction for conditional gene activation/inactivation
or lineage-tracing experiments. Such a manipulation
introduces Cre in all cells in which the utilized
promoter is active. To overcome the limited selec-
tivity of single promoters for cell-type-specific
recombination, we have explored the ‘dual promoter
combinatorial control’ of Cre activity, so that Cre
activity could be restricted to cells that express dual
protein markers. We efficiently reconstituted Cre
activity from two modified, inactive Cre fragments.
Cre re-association was greatly enhanced by fusing
the Cre fragments separately to peptides that
can form a tight antiparallel leucine zipper. The
co-expressed Cre fusion fragments showed
substantial activity in cultured cells. As proof of
principle of the utility of this technique in vivo for
manipulating genes specifically in dual-marker-
positive cells, we expressed each inactive Cre
fragments in transgenic mice via individual promo-
ters. Result showed the effective reconstitution
of Cre activates LoxP recombination in the
co-expressing cells.
INTRODUCTION
The Cre/LoxP system utilizes P1 bacteriophage Cre
recombinase to catalyze recombination between tandem
LoxP DNA sequences (1,2). This system has been widely
used in multiple organisms, including yeast (3), plants
(4–7) and animals (8–14). The Cre/LoxP technology is
particularly useful for mammalian genetics, because it
allows the analyses of essential genes in speciﬁc organs by
gene inactivation (8–15) or controlled ectopic gene
expression (16,17). When combined with visible marker
proteins, Cre-LoxP-based gene activation allows for cell
marking and cell lineage analyses in living animals (17).
Speciﬁc gene promoters are usually utilized to drive Cre
expression in desired tissues. Thus, the promoter speci-
ﬁcity limits where Cre can be expressed. To this end, most
available promoters drive gene expression in multiple cell
types. This deﬁciency has greatly limited our ability to
manipulate genes within speciﬁc cells, such as stem cells
that can only be identiﬁed by their expression of several
molecular markers (18–20). An approach that introduces
Cre exclusively to cells that express more than one protein
marker would facilitate our understanding of the function
and fate of speciﬁc cells in vivo.
Active protein can be reconstituted from peptide
fragments of corresponding molecules. For some proteins,
fragmented peptides can directly re-associate to restore
activity (21–23). In other scenarios, assisted protein
reconstitution is required. In this latter case, protein can
be cleaved to two inactive fragments. Each fragment was
then fused to one of a pair of interacting protein motifs
respectively. The interacting motifs could bring the protein
fragments to proximity to facilitate eﬃcient reassembly
(23–30). Both the above schemes have been explored for
Cre activity reconstitution (31,32). In one report, cDNA
molecules were designed to produce two inactive Cre
halves in same cells. This approach, combined with
improving protein translation from Cre cDNA (33), was
reported to reconstitute 32.5% of wild-type Cre activity
(32). In the other case, cDNA molecules were constructed
to produce two inactive Cre moieties connected with
FK506-binding protein (FKBP12) and FKBP12-
rapmycin-associated-protein (FRP), respectively. Because
the interaction between FKBP12 and FRP was FK506
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moieties and FK506 were present (31,34). This method
restores  3–4% Cre activity (31). The usefulness of these
two systems in animal models has not been reported.
We attempted to reconstitute Cre in mouse cells that
express two protein markers. Because we could obtain less
than 2% Cre activity using the published Cre fragment
complementation process (32), we utilized assisted-Cre
reassembly for this purpose. The Cre open reading frame
(ORF) was cleaved into two cDNA fragments, each
encoding an inactive Cre peptide. Each cDNA fragment
was then fused to an ORF for one of two peptides that
could form antiparallel leucine zippers (35). This leucine
zipper was artiﬁcially designed and has been reported to
eﬀectively assist protein reconstitution in vitro and in vivo,
and these peptides do not seem to interfere with normal
cellular functions (25,28,35). When these two modiﬁed Cre
fragments were co-expressed in tissue culture,  30% Cre
activity could be restored, an 8-fold improvement over
previously published methods (31,32). When expressed in
the pancreatic tissue of transgenic mice from individual
promoters, the inactive Cre fragments eﬀectively induce
LoxP-based recombination. This approach opens the
possibility to study gene function or perform lineage
labeling in cells that express dual protein markers in
animal models.
MATERIALS AND METHODS
DNA constructs and transgenic mouse production
For cDNA encoding the fusion of leucine zipper-forming
peptides with Cre moieties (Figure 1), overlapping DNA
oligos were synthesized and PCR-ampliﬁed with nlsCre
cDNA [with a nuclear localization signal (NLS) present in
Cre’s n-terminus] as template (36). One ﬁnal cDNA ORF
(called nCre) encodes a protein with N-terminal half of
Cre fused with N-peptide at Cre C-terminus (with a NLS
at its n-terminus, Figure 1). The oligos utilized were: X5,
Nz1, Nz2, Nz3 and nZ4 (Table 1). Anther cDNA ORF
(called cCre) encodes a protein with the C-terminal half of
Cre fused with C-peptide at Cre n-terminus (Figure 1).
The DNA oligos used were: N3, Cz1, cZ2, cZ3 and cZ4
(Table 1). To add an extra nuclear localization signal
coding sequence to cCre in its 50end (to produce nlcCre),
we utilized the following oligos: Nlc, N3, Cz1, cZ2, cZ3
and cZ4 (Table 1). PCR fragments were cloned into the
pBluescriptKSII vector to produce pYW415, pYW429
and pYW418, respectively. The XhoI-NotI fragments
from these constructs were ligated into the corresponding
sites of the pCIG-expression vector, containing the CMV-
chicken-b actin promoter to drive gene expression, to
produce pYW427, pYW443 and pYW425 (37). For CMV-
stop-GFP, an EcoRI–SpeI fragment (contains a Poly A
signal) from pBS302 (38) was ligated into the EcoRI–SpeI
sites of pGreenlatern-1 to produce pYW421 (39). As
control for Cre activity assay, the full-length Cre (which
was PCR ampliﬁed and inserted into the XhoI–NotI sites
of the pCIG vector to produce pYW482. The oligos
utilized were: fc1 and fc2 (Table 1). In order to use human
ubiquitin promoter (Ubc) to drive nlcCre expression,
the SalI (ﬁll-in)–NcoI fragment from pYW418 was cloned
into the NcoI–NotI (ﬁll-in) site of Ui4-GFP-SIBR vector
(40). Note all reading frames contain an idealized ‘Kozak
sequence’ CCACC before ATG. To amplify the a5, b1,
b1-nls fragments reported in (32), DNA oligos (X5+T5),
(N3+T3) and (N3+nlsb) were utilized. The pCIG
vector was utilized to drive the expression of these
fragments as well.
Figure 1. A diagram of the half-Cre molecules and the interacting
peptide sequences. (A) The Cre molecule was designed to be cleaved
into two molecules between two glycine residues (amino acid residues
190–191, as numbered in X03453). The N-terminal half was fused with
one of a pair peptides that form a leucine zipper (N-peptide), whereas
the C-terminal half was fused with the other peptide (C-peptide).
(B) The C- and N-peptide sequences.
Table 1. DNA oligos sequence utilized in this report
Primer name Primer sequence
T3 gtcgaccaccatggttaaagatatctcacgtactg
T5 gcggccgctcaaatatggattaacattctcccac
nX5 actcgagccaccatggcacccaagaagaagaggaaggtgtcc
N3 gcggccgcctaatcgccatcttccagcaggc
Cz1 actcgagaccaccatggtgtccgaacaactggagaagaagctcca
Cz2 ggctctcgaaaagaagctggctcaactcgaatggaagaatcaagc
Cz3 ctcgaatggaagaatcaagctctggaaaagaagctcgcccaaggctc
Nlc actcgagaccaccatggtgcccaagaagaagaggaaggtgtccga
acaactggagaaga
Cz4 gaaaagaagctcgcccaaggctctggtgggagaatgttaatccatatt
Nz1 tgcggccgctcattgagccagctccttcttcagagcttggagttcccact
Nz2 ttcagagcttggagttcccacttcagctgagccagttccttcttattagcttg
Nz3 gccagttccttcttattagcttggagctccttcttcagggcaccag
Nz4 ctccttcttcagggcaccagaaccaccgtcagtacgtgagatatc
PA1 tagcttgggatctttgtgaaggaaccttacttct
PA2 ggcggccgcagatcgatccagacatgataagatac
Fc1 ctcgagccaccatggcacccaagaagaagaggaaggtg
cga ccttcacaaagatcccaagctaga
Nz1 tggttatgcggcggatccgaaaa
Cz1 tccgtctctggtgtagctgatga
Fc2 gcggccgcagatctaatcgccatcttcca
X5 ctcgagccaccatgtccaatttactgaccgtacac
nlsb gcggccgcttacaccttccttttctttttcggaccatcgccatcttccagcag
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sequences from pGreenlatern1 were inserted into the SmaI
site of pBluescript KSII, producing pGD103 (oligonucleo-
tides utilized: pA1, pA2; Table 1). The XhoI–NotI (ﬁlled-
in)-digested nCre or nlcCre fragments were inserted into
the XhoI–EcoRV site of pGD103, producing YW452
and YW451, respectively. Finally, XhoI (ﬁlled-in)–NotI
fragments from YW452 and YW451 were inserted down-
stream of the murine Pdx1 promoter (SmaI/NotI-
restricted plasmid #571; gift from C. Wright). Inserts
were released with SalI–NotI for transgenic animal
production in the Shared ES Cell/Transgenic Animal
Resources in Vanderbilt Medical Center. nCre
tg and
nlcCre
tg genotyping was with ng1 and cga oligonucleotides
(Table 1). R26R-EYFP (R26YFP) and Z/AP reporter
animals genotyping, and alkaline phosphatase detection
was by published methods (36,41). All mouse care,
handling and crosses followed IACUC protocol M/03/
354 (Gu), approved by the Animal Welfare Committee of
Vanderbilt Medical Center.
Cre activity assay
A reporter plasmid (YW421) expressing eGFP Cre
dependently was used to assay Cre activity. Reporter
YW421, plus cCre or nCre plasmids (or both), and
mCherry-producing plasmid (42) were co-transfected into
HK293 cells using calcium-phosphate-based technique.
After 14–16h, transfected cells were analyzed by ﬂow
cytometry for ﬂuorescence expression. The percentage of
red cells that express eGFP was plotted against the Cre
plasmid(s) concentration. For most transfections, 0.2mg
YW421, 0.1mg mCherry and 0.1–2ng Cre-expressing
plasmids were utilized for each well of 12-well dishes.
With bigger wells, the plasmid amount was scaled-up
proportional to the well area. To ensure that the Cre
activity comparisons were made in a linear range, a
standard curve was constructed varying the concentration
of Cre-producing plasmid, measuring the output green/red
ratio. Reconstituted Cre activity was calculated against
this standard curve. All assays used a minimum of
triplicate samples. All assays utilized nlsCre as a control.
Immunofluorescence/immunohistochemistry
Established protocols were used. Brieﬂy, tissues were ﬁxed
in 4% paraformaldehyde overnight at 48C, or 4h at room
temperature, and prepared as frozen sections. Frozen
sections conserve GFP ﬂuorescence. Primary antibodies
used were: guinea pig anti-insulin and guinea pig anti-
glucagon (Dako, Carpinteria, CA, USA); rabbit anti-SS,
guinea pig anti-PP (In Vitrogen, Carlsbad, CA, USA);
rabbit anti-amylase, biotinylated Dolichos biﬂorus agglu-
tinin (DBA, Sigma, St Louis, MO, USA). Secondary
antibodies used were: Cy3-conjugated donkey anti-rabbit
IgG, Cy3-conjugated donkey anti-guinea pig IgG,
Cy3-conjugated streptavidin (Jackson Immunoresearch,
West Grove, PA, USA). Alkaline phosphatase staining
followed reported protocols (43). All antibodies utilized
1:1000 dilutions.
Microscopy
For whole mount YFP ﬂuorescence, tissues were dissected
and ﬁxed in 4% paraformaldehyde (overnight, 48C),
washed and mounted in PBS in chambers on glass slides.
Samples were observed using either inverted ﬂuorescence
microscope (for regular observations) or confocal micro-
scopy (for high quality pictures). Confocal imaging
was also utilized to observe immunoﬂuorescence-stained
samples. Typically, 0.4mm optical z-sections were taken
for thick samples. A maximum of two adjacent optical
sections were stacked and projected to produce a high
quality picture for each ﬁgure.
RESULTS
Creatinginactive Cre fragmentsfor reconstitution
Reconstituting Cre activity from two inactive peptide
fragments could beneﬁt from a pair of interacting protein
motifs to bring Cre fragments to proximity for refolding.
Additionally, Cre ORF needs to be cleaved at a speciﬁc
site so that the encoded Cre fragments will be inactive, yet
are able to reassemble into an active molecule when
brought together.
We considered several criteria in choosing interacting
protein motifs to assist in Cre reconstitution, including
high aﬃnity, high speciﬁcity, and lack of dominant-
negative eﬀects in living cells. The reported pair of
antiparallel, heterodimer leucine zipper-forming peptides
(Figure 1, named as N- and C-peptide) ﬁt this proﬁle
(44,45). These peptides were shown to eﬀectively assist
protein folding both in vitro and in vivo with no detectable
dominant negative eﬀects in living animals (24,25,44,45).
To choose the best point to separate Cre into two
portions, we examined the Cre 3D structure for the
residues and secondary structures that are crucial for its
activity (4,32,46). We choose to generate open reading
frames (ORF) which encodes Cre amino acid residues
1–190 and 191–343, separated between two glycine
residues at 190 and 191 (Figure 1). The ﬂexibility of the
peptide bond between glycine and other amino acid
residues makes it more likely to tolerate addition of
extra peptides without disrupting the secondary and
tertiary structure of Cre. In addition, these two glycine
residues are localized between two b-sheets and are
expected to point away from the DNA elements during
recombination (46). Therefore, connecting leucine zippers
with each half of the Cre protein at this position is
expected to minimally interfere with Cre function.
We derived three cDNA ORFs that encode three Cre
fragments, nCre, cCre and nlcCre, for Cre reconstitution
(Figure 1A). nCre was a fusion between the N-peptide to
the N-terminal half Cre. We included the SV40 large
T antigen NLS in the N-terminus of this molecule. cCre
was a fusion between the C-peptide to the C-terminal half
Cre (Figure 1B). nlcCre also contains a SV40 large
T antigen NLS in its n-terminus, otherwise, it is identical
to cCre (Figure 1). The presence of an NLS in both N- and
C-terminal half Cre molecules respectively is likely to
restrict both molecules in the nucleus and allow for
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protein fragments, the ORFs were put under the control
of the CMV-b actin promoter in the pCIG vector.
Leucine zipper-forming peptides inCre fragments
assist Cre reconstitution
The substrate for testing reconstituted Cre activity was a
reporter plasmid that produces eGFP in a Cre-dependent
manner (Figure 2A). The reporter plasmid was transfected
into HEK293 cells in large excess (see Materials and
methods section), together with Cre-producing plasmids.
An mCherry-producing plasmid (42) was co-transfected as
a control for cell transfection eﬃciency, with the green/red
ﬂuorescence ratio providing an index for Cre activity.
When 0.1–1ng Cre-producing plasmid was used per well
(6-well dishes), the green/red ﬂuorescence ratio versus
[Cre] was linearly correlated (Figure 2B–D), demonstrat-
ing that this method could be used for Cre activity assay.
With this activity assay, we carefully compared the Cre
activity restoration using unassisted and assisted recon-
stitution approaches. We generated three ORFs that
encode the a5, b1 and b1nls peptides reported in
Casanova et al. (32) and put them under the control of
the pCIG promoter. These fragments did not have
interaction motifs, yet were reported to reconstitute
substantial Cre activity. Using our established assay, we
found that both (a5+b1) and (a5+b1nls) restored <2%
Cre activity (Figure 2E and F). Yet the same
assay scheme revealed that a combination of nCre and
cCre reconstituted 12.1 2.6% recombinase activity of
intact Cre molecule, whereas nCre and nlcCre recovers
27.2 3.7% Cre activity (Figure 2E and F). These results
demonstrate the feasibility of reconstituting signiﬁcant
Cre activity in cell culture and the importance of
interacting leucine zippers for increased Cre
reconstitution.
In order to further examine whether a 1:1 nCre and
nlcCre molecular ratio is necessary for reconstituting Cre
activity, we utilized the CMV-b actin and a weaker human
ubiquitin promoter (Ubc) to drive nCre and nlcCre
expression respectively in same cells (40). Result showed
that a combination of pCIG-nCre and Ubc-nlcCre could
also reconstitute substantial, although lower, Cre activity
(Figure 2E). Additionally, we co-transfected a constant
concentration of pCIG-nCre and various amount of pCIG-
nlcCre plasmids to examine Cre activity restoration. As
shown in Figure 2G, substantial Cre activity could be
restored at all molecular ratios tested, demonstrating that
using promoters of diﬀerent strength to drive nCre and
nlcCre respectively would not prevent Cre reconstitution.
Cre activity reconstitution in transgenic mouse cells
To determine whether assisted-Cre reconstitution would
be feasible in vivo, we used a Pdx1 promoter to drive nCre
and nlcCre expression in transgenic mice (Pdx1-nCre and
Pdx1-nlcCre). The Pdx1 promoter is well characterized,
with expression restricted to all cells in the pancreas, as
well as posterior foregut cells of the duodenum and antral
stomach (47,48). Four Pdx1-nCre (nCre
tg1–4) and six
Pdx1-nlcCre (nlcCre
tg1–6) independent transgenic mouse
lines were derived (Figure 3A).
We ﬁrst crossed the nlcCre
tg1 line with all four nCre
tg
lines to determine whether Cre activity could be recon-
stituted, using the Z/AP reporter allele’s Cre-dependent
activation of alkaline phosphatase (43). Two lines, nCre
tg1
and nCre
tg3, when combined with nlcCre
tg1, showed AP
activity in  5% of pancreatic cells in newborn animals
(data not shown). The nCre
tg2 and nCre
tg4 lines showed no
detectable recombination when combined with nlcCre
tg1
and Z/AP. Semi-quantitative RT-PCR veriﬁed that these
two latter lines express nearly undetectable levels of nCre
mRNA (data not shown), and were sacriﬁced. As
expected, neither nlcCre
tg nor nCre
tg alone could induce
Z/AP recombination (data not shown).
We next utilized nCre
tg1 to determine which of the six
nlcCre
tg transgenic lines gave the highest recombination
eﬃciency (Figure 3B). We switched to the R26R-EYFP
mouse line (41) for this experiment because of the
convenience of observing YFP ﬂuorescence as a reporter
for Cre activity (Figure 3). Neonatal nCre
tg1; nlcCre
tg2;
R26R-EYFP and nCre
tg1; nlcCre
tg5; R26R-EYFP animals
had 31.2 4.1 (n=4) and 22.6 2.9% (n=3) pancreatic
cells recombined respectively, whereas, nlcCre
tg1,
nlcCre
tg3, nlcCre
tg4 and nlcCre
tg6 mouse lines showed
3–17% pancreatic cells recombined when they were
combined with nCre
tg1 and R26R-EYFP (data not
shown). Our subsequent characterization used the
nCre
tg1 and nlcCre
tg2 transgenic lines.
Cre activity is detectedin early embryonic stages
We next assessed whether there was a time dependency to
the reconstitution of Cre activity as compared to the
activity of the Pdx1 promoter, by assessing YFP expres-
sion in nCre
tg1; nlcCre
tg2; R26R-EYFP pancreata at
several stages of embryogenesis. Robust YFP expression
in the pancreatic region was observed at E13.0 (8.1 3.1%
of all pancreatic cells counted in four pancreatic buds,
Figure 4A–C), but not at E11.5 (data not shown). The
percentage of labeled cells increased gradually during
embryogenesis, so that at E15.5 and E17.5,  16.4 2.9%
or 26.2 3.7% (n=4), respectively, of pancreatic cells
expressed YFP (Figure 4D and E and data not shown).
From birth to 2-month-old adults, the overall percentage
of YFP
+ pancreatic cells remained relatively stable (data
not shown), consistent with the idea that the bulk of the
pancreatic mass comprises exocrine tissues that express
only a low level of Pdx1, and as such might not reach the
Cre threshold for recombination of the reporter allele.
We examined YFP expression in Pdx1-producing cells
at corresponding ages (Figure 4G–I) using the Pdx1-Cre
tg
animals (39). Robust YFP expression was observed in
more than half of the Pdx1
+ pancreatic cells at E10.5.
After E13.0, most, if not all, of the Pdx1
+ pancreatic cells
had turned on YFP expression. These results demonstrate
that substantial Cre activity could be restored in early
embryonic stages. Yet a delayed recombination and a
mosaic pattern are likely to result using this Cre
reconstitution approach, as opposed to the conventional
Cre molecule.
e126 Nucleic Acids Research, 2007, Vol. 35, No. 19 PAGE4 OF 9Figure 2. Assisted Cre reconstitution restores substantial Cre activity in cell culture. (A) The structure of the Cre reporter. EGFP could be expressed
only after Cre-mediated excision of the stop signal. (B1–B3) One example of Cre activity assays. (B1) EGFP expression (green) reported detectable
Cre activity. (B3) mCherry expression (magenta) indicates transfected cells. (B2) Merge of B1 and B3. (C) An example of ﬂow cytometry analysis for
Cre activity (0.5ng pCIG-Cre plasmid/well). In the four quadrants (R1–R4), R1 represents untransfected cells; R2, transfected cells without
detectable Cre activity; R3, transfected cells with active Cre; R4, cells with active Cre yet have lost mCherry expression. The percentage of each
cell type is labeled. The ratio of R3/(R2+R3) is used as Cre activity index. (D) The plot of GFP
+/mCherry
+ cells [=R3/(R2+R3)] versus the
amount of Cre-expressing plasmid. (E) Four assays for the relative Cre activity reconstituted from various Cre fragments. The four DNA samples
used were (labeled below each dot plot): no Cre control, pCIG- Cre+pCIG- Cre-nls, pCIG-nCre+pCIG-nlcCre; pCIG-nCre+Ubc-nlcCre
(all plasmids were transfected at 2ng/well). Note the low GFP background when no Cre activity is present. (F) Relative Cre activity restoration
when diﬀerent Cre fragments are utilized for complementation. (G) Relative Cre activity with a combination of 1ng of pCIG-nCre with various
amount of pCIG-nlcCre.
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cell-labeling efficiency
One potential application for this Cre reconstitution
approach is to mark and study the lineage of progenitor/
stem cells that express two protein markers. It is possible
that a higher percentage of cell labeling would be observed
in the presence of two reporter alleles. We therefore
analyzed nCre
tg1; nlcCre
tg2; R26R-EYFP/R26R-EYFP
embryos. Surprisingly, 63.2 5.4% (n=4) of pancreatic
cells express YFP at E17.5, more than double that of the
nCre
tg1; nlcCre
tg2; R26R-EYFP littermates (26.5 4.9%,
n=3). This result demonstrates that the presence of two
ﬂoxed reporter alleles substantially increases the chance of
introducing DNA recombination (in the presence of a
given amount of Cre), such that more complete lineage
labeling would be obtained in the presence of two reporter
alleles. At present, we do not understand why this
increased recombination occur with the presence of two
ﬂoxed alleles and it remains to be seen whether this same
result holds for the other reporter alleles that are
commonly in use in lineage tracing experiments in vivo.
Reconstituted Cre induces recombination inall
pancreatic cell types
Eﬀective application of Cre reconstitution requires Cre to
be restored in a cell context-independent manner. We
therefore examined whether all pancreatic cell types could
be labeled with Cre reporter expression in neonatal
and adult nCre
tg1; nlcCre
tg2; R26R-EYFP pancreata. The
vertebrate pancreas contains two exocrine cell types, the
pancreatic duct and acinar cells, and four major endocrine
cell types, a, b, d and PP cells. The pancreatic duct cells
can be recognized by their speciﬁc expression of an epitope
that binds to the DBA lectin, whereas the acinar cells, a, b,
d and PP cells can be recognized by their expression of
amylase (amy), glucagon (glc), insulin (ins), somatostatin
(SS) and pancreatic polypeptide (43), respectively. The
acinar cells are derived from pancreatic progenitors
that continuously express high levels of Pdx1 (36). In
diﬀerentiated acinar cells, a low level of Pdx1 expression is
maintained (47). The b and d cells are also derived from
Pdx1
+ progenitors and they maintain a high level of Pdx1
expression throughout life. On the contrary, the pancre-
atic duct, a and PP cells only transiently express Pdx1
during their diﬀerentiation. If nCre and nlcCre can
reassemble in a cell type independent fashion, we expect
that all pancreatic cell types can be labeled with Cre
reporter expression, and a larger proportion of acinar, b
and d cells should be labeled, than that of duct, a and PP
cells. Indeed, 28.1 4.8%, 32.5 3.7% and 21.7 6.1%
acinar, b and d cells in neonatal nCre
tg1; nlcCre
tg2;
R26YFP pancreas expressed YFP (n=4, Figure 5A–C).
Whereas only 8.3 4.8%, 4.4 2.3% and 12.5 3.7%
duct, a and PP cells expressed YFP at the same age (n=4,
Figure 5D–F).
Because pancreatic b cells maintain high levels of Pdx1
expression in postnatal animals, we expected that Cre
activity will be maintained in these cells in the nCre
tg1;
nlcCre
tg2; R26YFP animals and the labeling index of the
b cells should increase over age. Indeed, the percentage of
Figure 3. Transgene structures and a mouse cross scheme. (A) DNA
constructs that utilize a Pdx1 promoter to drive the expression of nCre
and nlcCre. (B) An example of mouse cross scheme to produce animals
of desired genotype.
Figure 4. Reconstituted Cre activates reporter gene expression in
transgenic mice. Green ﬂuorescence is from YFP, indicating cells that
have undergone Cre-mediated recombination. (A) E13.0 nCre
tg1;
R26YFP pancreas. The green channel in this picture was enhanced to
visualize the lobular pancreatic structure in the dorsal pancreas.
(B and C) The dorsal and ventral lobe of a nCre
tg1; nlcCre
tg2;
R26YFP pancreas (E13.0). (D and E) The dorsal and ventral lobe of a
nCre
tg1; nlcCre
tg2; R26YFP pancreas (E17.5). (F) The ventral pancreas
of a E17.5 nCre
tg1; nlcCre
tg2; R26YFP/R26YFP animal. (G–I)
Pancreatic regions of Pdx1-Cre
tg; R26YFP animals. (G) E10.5; (H)
E13.0; (I) Neonatal. Note the presence of YFP
+ cells in the duodenum
(F). dp, dorsal pancreas; vp, ventral pancreas; du, duodenum.
Bars=40mm.
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+ b cells increased to  62% in 2-month-old
pancreata (Figure 5G). On the contrary, the labeling
indices of cells that do not express detectable levels of
Pdx1 (e.g. the duct and a cells) in postnatal pancreas did
not increase, even though these labeled cells were still
present in 2-month-old pancreas (Figure 5H and I).
DISCUSSION
The Cre/LoxP-based DNA recombination has revolution-
ized mammalian genetic analysis (14,17). With tissue-
speciﬁc Cre production or temporally controlled Cre
activity (10), this system allowed for precise gene
manipulation in spatially and temporally desirable man-
ners, thus revealing gene functions and cell lineages during
animal development and tissue regeneration. One chal-
lenge for this system is obtaining proper promoters to
drive Cre expression with the appropriate cell-type
speciﬁcity. This is a critical issue for studying progenitor
or stem cells, which usually need multiple markers for
identiﬁcation. Here we report the successful reconstitution
of Cre activity from modiﬁed, inactive Cre fragments in
both cell culture as well as in transgenic mice. By
modifying this approach such that the expression of the
individual inactive Cre fragments is driven by separate
promoters, with a deﬁned overlap of expression, such a
system could prove extremely versatile in allowing
controlled DNA rearrangements (gene inactivation,
ectopic gene expression and lineage labeling) in highly
spatially or temporally deﬁned cell populations.
Previous Cre activity assays introduced Cre-expressing
constructs to cells that carry one copy of a reporter gene,
which expresses LacZ upon LoxP-based recombination
(31,32,34). Because only one single event is required for
turning on LacZ expression, it is not clear whether this
approach can accurately determine Cre activity (49).
LoxP-based chromosomal integration of extra chromoso-
mal circular DNA could be used for a more accurate Cre
activity assay, yet this latter approach is time consuming
and proper cell selection is required (49). We devised a
straightforward Cre activity assay by providing a large
excess of Cre reporter that could be co-transfected with
Cre-expressing plasmids. Within a reasonable Cre con-
centration range, the percentage of cells that turns on
reporter expression displayed a linear correlation with the
amount of Cre-producing plasmid transfected, demon-
strating that this approach could be used to assay for Cre
activity. With ﬂuorescent protein reporters and ﬂow
cytometry, this Cre assay was rapid, being accomplished
within two days. Using this assay, we showed that
unassisted Cre reconstitution could only recover <2%
Cre activity, whereas assisted Cre reassembly recovers
nearly 30% Cre activity, demonstrating the key impor-
tance of our protein-interaction-motif-based modiﬁcation.
Furthermore, we compared this assisted-Cre reconstitu-
tion approach with the unassisted Cre complementation
method (32) side by side in tissue culture. Results showed
that the former protocol allowed for Cre recovery at least
10-fold more eﬃciently than the latter scheme. These
analyses suggest that assisted-Cre reconstitution is more
desirable for introducing widespread DNA recombination
within speciﬁc tissues, whereas the simple Cre-comple-
mentation approach (32) might be more useful when
recombination in a small number of cells is desired, for
example, for mosaic analyses or clonal cell lineage tracing.
The reconstituted Cre activity is suﬃcient to induce
LoxP-based DNA recombination in both tissue culture
and in transgenic mice. However, a mosaic recombination
pattern was observed, i.e. not all cells that are expected to
express both Cre moieties undergo recombination in
transgenic mouse. There are two possible explanations
for this ﬁnding. First, the reconstituted Cre activity is too
low to induce recombination in all Pdx1-expressing cells.
Second, the Pdx1 promoter-controlled transgene expres-
sion is of a mosaic pattern per se. Because the Pdx1
promoter used in this study rarely expresses transgene in
mosaic pattern (36,50,51), and multiple independent
mouse lines tested in this study all produce a similar
recombination pattern, this latter possibility is an unlikely
scenario.
This Cre-complementation technique could potentially
be utilized for loss of gene function analyses, ectopic gene
expression and cell lineage analyses. Although the low Cre
activity recovery is not ideal for inactivating gene
function, generation of mosaic pattern is advantageous
in assessing cell clonality for lineage tracing. It could also
allow for detailed analyses of the mutant cell behaviors if
Figure 5. Cre activity can be reconstituted in all pancreatic progenitors.
Green ﬂuorescence indicated YFP
+ cells. Shown were pancreatic
regions only. Magenta ﬂuorescence indicated the expression of
pancreatic markers, as marked in each panel. (A–F) Neonatal pancreas.
(G–I) Two-month-old adult pancreas. Yellow arrows, double positive
cells. amy, amylase; ins, insulin; SS, somatostatin; DBA, Dolichos-
Biﬂorus agglutinin; glc, glucagon; PP, pancreatic polypeptide.
Bar=20mm.
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the lethality caused by a more widespread ectopic gene
expression or loss of gene activity. Results obtained
from such analysis could shed light on whether a gene
exerts its function in a cell autonomous or non-
autonomous fashion.
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